• Mashup Score: 0

    This review identifies problems in current media reports of new cancer advances – especially with undue use of superlatives and hype. Given the frequency with which patients access this information and the potential for it to influence policy, there is a need for additional research in this space in …

    Tweet Tweets with this article
    • PUBLISHED: While media coverage of cancer treatments is good, it can sometimes create unrealistic expectations. In this review, we expand on this important topic.@AggarwalOnc @Jackeulade10 @BrandonNiyibizi @JPGalica @SullivanProf .https://t.co/ECtvKE9scx https://t.co/MyfYHts3iX

  • Mashup Score: 8

    Disparities in cancer research persist around the world. This is especially true in global health research, where high-income countries (HICs) continue to set global health priorities further creating several imbalances in how research is conducted in low and middle-income countries (LMICs). Cancer research disparities in Africa can be attributed to a vicious cycle of challenges in the research…

    Tweet Tweets with this article
    • JUST PUBLISHED: Disparities in cancer research persist around the globe. This is especially true in global oncology research. In this article:https://t.co/wpWFZ02DKc we shade light on what we believe are major reasons. Enjoy the read and share your thoughts. https://t.co/GcffMMbfEt

  • Mashup Score: 0

    Health-care systems in sub-Saharan Africa are considered to be new markets for pharmaceutical companies. This perception is particularly relevant within oncology, as the pharmaceutical industry has changed strategic priorities in the past 10 years to focus on cancer. Since the 1930s, pharmaceutical companies have used advertisements, sample drugs, gifts, paid speaking engagements, advisory…

    Tweet Tweets with this article
    • Industry-doctor relationships are becoming increasingly common in sub-Saharan Africa and other low- and middle-income countries. These relationships bring both risks and benefits.@nazik_hammad @akillesm @MelTav85 @HamidMD10 @m_mutebi @VanderpuyeVerna https://t.co/SDs74CemUt https://t.co/6V1Zjsx89i

  • Mashup Score: 0

    When a cervical cancer patient is done with treatment, they usually go back for check-ups for a period of five years. This is done to see whether the patient has not developed…

    Tweet Tweets with this article
    • ...where patients have to travels distances to only one existing cancer centre. To tackle this issue, we are piloting a decentralized survivorship care plan for cervical cancer in Rwanda through @ASCO @ConquerCancerFd support. https://t.co/iwSG5bPpAj.